SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

Advaxis, Inc. (ADXS)

ADXS RSS Feed
Add ADXS Price Alert      Hide Sticky   Hide Intro
Moderator: XenaLives, DewDiligence, jaxstraw, scottmiyadi, maplestory
Search This Board: 
Last Post: 10/22/2017 6:10:38 PM - Followers: 320 - Board type: Free - Posts Today: 63


 

 

RE-ENGAGING THE IMMUNE SYSTEM TO FIGHT CANCER

Advaxis is a clinical-stage biotechnology company developing multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer. The Advaxis technology, using bioengineered live attenuated bacteria, listeria monocytogenes (Lm), actively suppresses key components in the tumor microenvironment that contribute to the tumors growth and protection from immunologic attack.

 

Additional Resources

Company Website
 


Share Structure

 
Shares Outstanding 
 
39,639,000
 

 

 



 
SureTrader
Interactive Brokers Advertisement
ADXS
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ADXS News: Statement of Changes in Beneficial Ownership (4) 10/12/2017 03:55:36 PM
ADXS News: Statement of Changes in Beneficial Ownership (4) 10/02/2017 04:31:51 PM
ADXS News: Statement of Changes in Beneficial Ownership (4) 10/02/2017 04:31:51 PM
ADXS News: Amended Statement of Ownership (sc 13g/a) 09/27/2017 08:51:46 AM
ADXS News: Statement of Changes in Beneficial Ownership (4) 09/26/2017 05:26:54 PM
PostSubject
#38738  Sticky Note Re: AIM2CERV A similar 2 years of PFS DewDiligence 10/16/17 06:53:53 PM
#36885  Sticky Note What is Advaxis really worth if sold? mpreorder 10/01/17 01:09:24 PM
#30712  Sticky Note ADXS Board of Directors, please consider putting the fbg0316 08/22/17 10:26:25 AM
#7252  Sticky Note Full text of cancer-vaccine article from Oct 2016 DewDiligence 10/14/16 03:50:18 PM
#39503   "Vienna is beautiful any time of year, but corvatsch 10/22/17 06:10:38 PM
#39502   No way shareholders would accept a buyout under fbg0316 10/22/17 05:45:12 PM
#39501   Wow....really FBG......why not just say buy us for Keithz 10/22/17 05:02:53 PM
#39500   You have a point. Why argue, support raja48185 10/22/17 04:42:07 PM
#39499   NSS is real, this article explains the mechanics XenaLives 10/22/17 03:36:24 PM
#39498   if you look at the short numbers and tx_farmer 10/22/17 02:50:35 PM
#39497   Well put. And that is exactly what happened trading_cyclist 10/22/17 02:50:27 PM
#39496   So if you "lend" shares, you don't have oakrock 10/22/17 02:46:12 PM
#39495   mp and Gantor - good points. I attilathehunt 10/22/17 01:56:32 PM
#39492   Nicely said Gantor. attilathehunt 10/22/17 01:24:42 PM
#39491   Given the value destruction, incompetent management and the fbg0316 10/22/17 01:16:06 PM
#39489   I have come to peace with my ADXS khaled_shatila 10/22/17 12:45:48 PM
#39488   I think it is reflecting zero here,because I blueyedcatch 10/22/17 12:33:57 PM
#39487   Cancer vaccines, long considered failures, are hot again. Julius_Kelp 10/22/17 12:08:28 PM
#39486   And the same could be said for Adage Traderbx 10/22/17 11:27:41 AM
#39485   Good views ... runcaly 10/22/17 11:22:27 AM
#39484   Well, we both agree completely that ADXS is Gantor50 10/22/17 11:07:24 AM
#39483   Our analyst price targets hav`nt changed to the blueyedcatch 10/22/17 10:56:38 AM
#39482   Why don't you ask the Cantor analyst if ignatiusrielly35 10/22/17 10:39:07 AM
#39481   Traderx, Personally I think the short interest report on Gantor50 10/22/17 10:38:55 AM
#39480   I have mentioned this before, but just to Gantor50 10/22/17 10:34:51 AM
#39479   "Short interest in ADXS won't ever go to Traderbx 10/22/17 10:31:22 AM
#39477   Mpreorder, yes, I do agree that Lombardo will Gantor50 10/22/17 10:26:56 AM
#39474   Thanks for your reply Gantor. I confess mpreorder 10/22/17 09:58:19 AM
#39473   Well, the market (i.e. Manipulators) are wrong. If ignatiusrielly35 10/22/17 09:55:07 AM
#39472   It's right around the consensus valuation Wall Street fbg0316 10/22/17 09:51:49 AM
#39470   Mpreorder, this might be one of the few Gantor50 10/22/17 09:46:48 AM
#39467   Blue I am incredibly bullish as I believe fbg0316 10/22/17 09:38:17 AM
#39464   Is not naming Lombardo permanent CEO a bit mpreorder 10/22/17 09:26:52 AM
#39463   Hey Blue: Thank you for checking out the dawson-m 10/22/17 09:26:35 AM
#39462   The market disagrees with you that ADXS is fbg0316 10/22/17 09:24:34 AM
#39461   KITE, with good Phase 3 results, is worth ignatiusrielly35 10/22/17 09:21:47 AM
#39459   Gantor, I agree with your view almost completely. ignatiusrielly35 10/22/17 09:12:32 AM
#39458   Also absolutely agreed. While at least we Gantor50 10/22/17 09:07:07 AM
#39457   Great post Gantor. At this point, given how fbg0316 10/22/17 09:06:19 AM
#39456   The rules have definitely changed with the lame huskercatman123 10/22/17 08:56:26 AM
#39455   Absolutely. In fact, this isn't just true Gantor50 10/22/17 08:49:09 AM
#39454   Of course, Gaj. They don't teach stock manipulation ignatiusrielly35 10/22/17 08:43:32 AM
#39453   I am of two opinions on ADXS… Gantor50 10/22/17 08:39:00 AM
#39452   Like I said folks give ADXS until Super sandman44 10/22/17 08:35:11 AM
#39451   Unethical policies are taught as trading strategy in rfrankmcm 10/22/17 08:33:50 AM
#39448   Jefferies London Health Conference Jcgmss 10/22/17 05:08:24 AM
#39446   Don't give up on 2017 yet. I attilathehunt 10/22/17 01:41:04 AM
#39444   and more likely than not more off the gajj 10/22/17 12:12:19 AM
#39443   Amen gajj 10/22/17 12:10:55 AM
#39442   I maintain that Advaxis will be a $100+ gajj 10/22/17 12:06:27 AM
#39441   I found it very interesting and I give gajj 10/22/17 12:03:15 AM
#39440   in house training I could believe (though they gajj 10/21/17 11:56:57 PM
#39435   The Morgan guy only confirmed what alot of ignatiusrielly35 10/21/17 09:58:57 PM
#39434   So if the shorts are covering why are fraud fighter 10/21/17 09:49:19 PM
PostSubject